These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30026556)

  • 1. Novel perspectives in the management of decompensated cirrhosis.
    Bernardi M; Caraceni P
    Nat Rev Gastroenterol Hepatol; 2018 Dec; 15(12):753-764. PubMed ID: 30026556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The search for disease-modifying agents in decompensated cirrhosis: From drug repurposing to drug discovery.
    Caraceni P; Abraldes JG; Ginès P; Newsome PN; Sarin SK
    J Hepatol; 2021 Jul; 75 Suppl 1():S118-S134. PubMed ID: 34039483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation and complications associated with cirrhosis of the liver.
    Poordad FF
    Curr Med Res Opin; 2015 May; 31(5):925-37. PubMed ID: 25697811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin in decompensated cirrhosis: new concepts and perspectives.
    Bernardi M; Angeli P; Claria J; Moreau R; Gines P; Jalan R; Caraceni P; Fernandez J; Gerbes AL; O'Brien AJ; Trebicka J; Thevenot T; Arroyo V
    Gut; 2020 Jun; 69(6):1127-1138. PubMed ID: 32102926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Cirrhosis Complications: Looking for Potential Disease Modifying Agents.
    Zaccherini G; Tufoni M; Bernardi M; Caraceni P
    J Clin Med; 2021 Oct; 10(19):. PubMed ID: 34640608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role and indications of albumin in advanced liver disease.
    Zaccherini G; Bernardi M
    Acta Gastroenterol Belg; 2019; 82(2):301-308. PubMed ID: 31314192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatitis C in patients who have decompensated cirrhosis.
    Everson GT
    Clin Liver Dis; 2005 Aug; 9(3):473-86, viii. PubMed ID: 16023978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Critically ill patients with decompensated liver cirrhosis - New aspects and intensive care management].
    Maschmeier M; Hüsing A; Schmidt H; Kabar I
    Dtsch Med Wochenschr; 2015 Oct; 140(20):1514-6. PubMed ID: 26445254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapeutic paradigm for patients with cirrhosis.
    Tsochatzis EA; Bosch J; Burroughs AK
    Hepatology; 2012 Nov; 56(5):1983-92. PubMed ID: 22729954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal and circulatory dysfunction in cirrhosis: current management and future perspectives.
    Solà E; Ginès P
    J Hepatol; 2010 Dec; 53(6):1135-45. PubMed ID: 20850887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.
    Møller S; Bendtsen F
    Liver Int; 2018 Apr; 38(4):570-580. PubMed ID: 28921803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver cirrhosis.
    Ginès P; Krag A; Abraldes JG; Solà E; Fabrellas N; Kamath PS
    Lancet; 2021 Oct; 398(10308):1359-1376. PubMed ID: 34543610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro: The Role of Albumin in Pre-Liver Transplant Management.
    Bernardi M; Zaccherini G; Caraceni P
    Liver Transpl; 2019 Jan; 25(1):128-134. PubMed ID: 30346096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complications of portal hypertension in the liver cirrhosis].
    Ivashkin VT
    Ross Fiziol Zh Im I M Sechenova; 2009 Oct; 95(10):1074-92. PubMed ID: 19957897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [News for usage of albumin in patients with liver disease].
    Cremonese C; Uschner FE; Trebicka J
    Dtsch Med Wochenschr; 2020 Jun; 145(11):722-726. PubMed ID: 32492740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic and Systemic Effects of Albumin in Patients with Advanced Liver Disease.
    Tufoni M; Baldassarre M; Zaccherini G; Antognoli A; Caraceni P
    Curr Hepatol Rep; 2020; 19(3):147-158. PubMed ID: 32837825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota-related complications in cirrhosis.
    Gómez-Hurtado I; Such J; Sanz Y; Francés R
    World J Gastroenterol; 2014 Nov; 20(42):15624-31. PubMed ID: 25400446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive care of the patient with cirrhosis.
    Olson JC; Wendon JA; Kramer DJ; Arroyo V; Jalan R; Garcia-Tsao G; Kamath PS
    Hepatology; 2011 Nov; 54(5):1864-72. PubMed ID: 21898477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis.
    Bernardi M; Moreau R; Angeli P; Schnabl B; Arroyo V
    J Hepatol; 2015 Nov; 63(5):1272-84. PubMed ID: 26192220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis.
    Qi X; Bai M; Yang Z; Yuan S; Zhang C; Han G; Fan D
    Med Hypotheses; 2011 Apr; 76(4):522-6. PubMed ID: 21216538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.